695 related articles for article (PubMed ID: 25053884)
1. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.
Donohue JF; Herje N; Crater G; Rickard K
Int J Chron Obstruct Pulmon Dis; 2014; 9():745-51. PubMed ID: 25053884
[TBL] [Abstract][Full Text] [Related]
2. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
[TBL] [Abstract][Full Text] [Related]
3. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
[TBL] [Abstract][Full Text] [Related]
4. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma [added].
Schneider A; Tilemann L; Schermer T; Gindner L; Laux G; Szecsenyi J; Meyer FJ
Respir Res; 2009 Mar; 10(1):15. PubMed ID: 19254389
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases.
Shi F; Qiu C; Yu J; Yang Y; Li B; Feng M; Zhang T; Liu W
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):232-239. PubMed ID: 29908540
[TBL] [Abstract][Full Text] [Related]
7. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
8. Converting F
Lassmann-Klee PG; Lehtimäki L; Lindholm T; Malmberg LP; Sovijärvi ARA; Piirilä PL
Clin Physiol Funct Imaging; 2019 Sep; 39(5):315-321. PubMed ID: 31058423
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD.
Bazeghi N; Gerds TA; Budtz-Jørgensen E; Hove J; Vestbo J
Respir Med; 2011 Sep; 105(9):1338-44. PubMed ID: 21530214
[TBL] [Abstract][Full Text] [Related]
10. Fractional Exhaled Nitric Oxide as an Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease (COPD) with or without Concurrent Diagnosis of Asthma: The Canadian Cohort Obstructive Lung Disease (CanCOLD).
Mostafavi-Pour-Manshadi SM; Naderi N; Mancino P; Li PZ; Tan W; Bourbeau J
COPD; 2020 Aug; 17(4):355-365. PubMed ID: 32584165
[TBL] [Abstract][Full Text] [Related]
11. Associations between occupational inhalation risks and FeNO levels in airway obstruction patients: results from the National Health and Nutrition Examination Survey, 2007-2012.
Huang YC; Yang MC
Int J Chron Obstruct Pulmon Dis; 2017; 12():3085-3093. PubMed ID: 29118577
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value and influencing factors of fractional exhaled nitric oxide in suspected asthma patients.
Wang Y; Li L; Han R; Lei W; Li Z; Li K; Kang J; Chen H; He Y
Int J Clin Exp Pathol; 2015; 8(5):5570-6. PubMed ID: 26191266
[TBL] [Abstract][Full Text] [Related]
13. Ability of Exhaled Nitric Oxide to Discriminate for Airflow Obstruction Among Frequent Exacerbators of Clinically Diagnosed Asthma.
Jalota L; Allison DR; Prajapati V; Vempilly JJ; Jain VV
Lung; 2018 Aug; 196(4):455-462. PubMed ID: 29916097
[TBL] [Abstract][Full Text] [Related]
14. Repeatability of exhaled nitric oxide measurements in patients with COPD.
Rouhos A; Kainu A; Piirilä P; Sarna S; Lindqvist A; Karjalainen J; Sovijärvi AR
Clin Physiol Funct Imaging; 2011 Jan; 31(1):26-31. PubMed ID: 21143751
[TBL] [Abstract][Full Text] [Related]
15. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
16. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
Li M; Yang T; He R; Li A; Dang W; Liu X; Chen M
Int J Chron Obstruct Pulmon Dis; 2020; 15():3025-3037. PubMed ID: 33244228
[TBL] [Abstract][Full Text] [Related]
17. FENO measurement and sputum analysis for diagnosing asthma in clinical practice.
Schneider A; Schwarzbach J; Faderl B; Welker L; Karsch-Völk M; Jörres RA
Respir Med; 2013 Feb; 107(2):209-16. PubMed ID: 23107283
[TBL] [Abstract][Full Text] [Related]
18. [Fractional exhaled nitric oxide in bronchial inflammatory lung diseases].
Xia Q; Pan P; Wang Z; Lu R; Hu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 39(4):365-70. PubMed ID: 24820276
[TBL] [Abstract][Full Text] [Related]
19. [Value of Fractional Exhaled Nitric Oxide after Using a Beta-2 Bronchodilator in the Differential Diagnosis of Bronchial Asthma and Chronic Obstructive Pulmonary Disease].
Ura M; Tanaka H; Takahashi K; Yamazaki H; Fujimoto K
Rinsho Byori; 2016 Feb; 64(2):127-32. PubMed ID: 27311275
[TBL] [Abstract][Full Text] [Related]
20. Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.
Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
BMJ Open; 2017 Dec; 7(12):e018954. PubMed ID: 29273668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
